Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative Lidocaine for Pulmonary Injury in Infants Following Cardiac Surgery
NCT07499154Phase 4Not yet recruiting
- Sponsor
- Children's Hospital, Zhejiang University School of Medicine
- Start
- Apr 2026
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Lidocaine Hydrochloride Injection, without epinephrine in acute lung injury (ALI), postoperative pulmonary complications (PPC), sponsored by Children's Hospital, Zhejiang University School of Medicine. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
acute lung injury (ALI)postoperative pulmonary complications (PPC)
Beyond the preview
Go deeper on NCT07499154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07499154.